申请人:Bayer Aktiengesellschaft
公开号:US03980780A1
公开(公告)日:1976-09-14
N-methyl-imidazole derivatives of the formula: ##EQU1## or a pharmaceutically acceptable non-toxic salt thereof, wherein X is an unsubstituted or substituted 6-membered heteroaromatic moiety having two nitro heteroatoms, Y is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety or an unsubstituted or substituted aryl moiety, and Z is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety, an unsubstituted or substituted aryl moiety, an unsubstituted or substituted pyridyl moiety or an alkoxycarbonyl moiety, Are useful as antimycotic agents.
式子为:##EQU1## 的N-甲基咪唑衍生物或其药学上可接受的非毒性盐,其中X是一个未取代或取代的6元杂环芳香基团,具有两个硝基杂原子,Y是未取代或取代的脂肪基团,未取代或取代的环脂基团,未取代或取代的芳基烷基团或未取代或取代的芳基基团,Z是未取代或取代的脂肪基团,未取代或取代的环脂基团,未取代或取代的芳基烷基团,未取代或取代的芳基基团,未取代或取代的吡啶基团或醇酸酯基团。这些衍生物可用作抗真菌剂。